BROACH LIFECARE HOSPITAL LIMIT
- Market cap
- ₹ 9 Cr.
- P/E
- 85.7x
- P/B
- 0.9x
- 52-week range
- 12.01 – 20.95
- ROE
- 1%
- ROCE
- 2.5%
- Dividend yield
- 0%
- Debt / equity
- 0
- Sector
- Healthcare Services
- Industry
- Hospital
- Listed on
- BSE SME
About
Broach Lifecare Hospital Limited is an India-based company. The Company operates boutique Hospitals under the brand, Maple Hospitals. It provides dedicated round-the-clock services to patients with heart ailments consisting of noninvasive cardiology services such as two-dimensional (2D) echocardiography, electrocardiography, tread mill test, Holter monitoring, ambulatory blood pressure measurement, stress test, dobutamine stress echocardiography. The Company also provides ballon mitral-valvuloplasty, permanent pacemaker implantation, cardiac resynchronization procedures, implantable cardioverter-defibrillator (AICD) implantation and procedures for congenital ailments such as coarctation of aorta, stenting and posterior descending artery closure. It also offers a complete range of diagnostic and therapeutic options such as endovascular revascularization, deep vein thrombosis treatment and peripheral angioplasty.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Hospital: 41 companies →BROACH LIFECARE HOSPITAL LIMIT against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)85.7 against a typical 48.9: pricier than most peers (1st = cheapest).29th of 40
- Sales growth+99.4% against a typical +21.1% from a year earlier.4th of 34
- Profit growth−148.9% against a typical +13% from a year earlier.29th of 31
- Share price, 3 months−15.3% against a typical −8.8%.22nd of 35
- Size₹ 8.5 Cr. market value against a typical ₹ 1,306.7 Cr. (1st = largest).36th of 36
Financials
Standalone figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 1 | 2 | 2 | 1 | 3 | 3 |
| Expenses | 1 | 1 | 1 | 1 | 2 | 3 |
| Operating Profit | 0 | 1 | 1 | 0 | 1 | −0 |
| OPM % | 42.2% | 38.2% | 35.9% | 12.4% | 20% | −0.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 1 | 1 | 0 | 0 | −0 |
| Tax % | 26.7% | 25% | 23.7% | 33.3% | 24.4% | 10% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | −0 |
| EPS in Rs | 0.49 | 1.05 | 0.72 | 0.15 | 0.51 | −0.38 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 48%
- TTM
- 89%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- −16%
- TTM
- −83%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 9%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| BROACH LIFECARE HOSPITAL LIMIT | ₹ 12.70 | ₹ 9 Cr. | 85.7x | 0.9x | 1% | — |
| Apollo Hospitals Enterprise | ₹ 7,730.00 | ₹ 1,11,146 Cr. | 61.7x | 12.8x | — | 8.1% |
| Max Healthcare Institute | ₹ 815.00 | ₹ 79,325 Cr. | 60.3x | 8.3x | — | 16.7% |
| Fortis Healthcare | ₹ 712.90 | ₹ 53,821 Cr. | 59.4x | 6.4x | — | 11.3% |
| Aster DM Healthcare | ₹ 644.75 | ₹ 56,272 Cr. | 88.2x | 8x | — | 7.4% |
| Global Health | ₹ 1,185.00 | ₹ 31,989 Cr. | 61.2x | 8.6x | — | 11.8% |
Management
- Urvi Mrunal Hindia
- Chief Financial Officer
- Swati Sharma
- Compliance Officer, Company Secretary
- Jaykumar Narendra Vyas
- Managing Director, Executive Director
- Shachi Jaykumar Vyas
- Whole Time Director
- Shimoli Dalwadi
- Accounts Head
Prices are delayed and for information only. Nothing on this page is investment advice.